SAB Biotherapeutics (SABS) Current Leases (2020 - 2026)
SAB Biotherapeutics (SABS) posted Current Leases of $763705.0 for Q1 2026, up 396.02% on a QoQ basis from $153967.0 in Q4 2025, and up 425.49% year-over-year from $145333.0 in Q1 2025.
SAB Biotherapeutics (SABS) Current Leases (2020 - 2026) Analysis & Trends
SAB Biotherapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $763705.0 for Q1 2026.
- Quarterly Current Leases rose 425.49% year-over-year to $763705.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $763705.0 (up 425.49% YoY) and the FY2025 annual result came in at $153967.0, up 8.0% from the prior year.
- Current Leases was $763705.0 for Q1 2026 at SAB Biotherapeutics, up from $153967.0 in the prior quarter.
- Across five years, Current Leases topped out at $1.2 million in Q1 2022 and bottomed at $127022.0 in Q2 2023.
- A 5-year average of $417098.4 and a median of $153967.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases sank 78.72% — and 2025, when it jumped 498.72%.
- SAB Biotherapeutics' Current Leases stood at $132788.0 in 2022, then soared by 404.52% to $669946.0 in 2023, then sank by 78.72% to $142563.0 in 2024, then advanced by 8.0% to $153967.0 in 2025, then jumped by 396.02% to $763705.0 in 2026.
- Business Quant data shows SABS's Current Leases at $763705.0 in Q1 2026, $153967.0 in Q4 2025, and $837286.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | SAB Biotherapeutics | 170.64 Mn | 170.64 Mn | - | 763,705.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 763,705.00 |
| Dec 31, 2025 | 153,967.00 |
| Sep 30, 2025 | 837,286.00 |
| Jun 30, 2025 | 815,064.00 |
| Mar 31, 2025 | 145,333.00 |
| Dec 31, 2024 | 142,563.00 |
| Sep 30, 2024 | 139,847.00 |
| Jun 30, 2024 | 137,182.00 |
| Mar 31, 2024 | 542,841.00 |
| Dec 31, 2023 | 669,946.00 |
| Sep 30, 2023 | 528,778.00 |
| Jun 30, 2023 | 127,022.00 |
| Mar 31, 2023 | 518,012.00 |
| Dec 31, 2022 | 132,788.00 |
| Sep 30, 2022 | 140,891.00 |
| Jun 30, 2022 | 140,767.00 |
| Mar 31, 2022 | 1.15 Mn |
| Dec 31, 2021 | 161,050.00 |
| Dec 31, 2020 | 924,265.00 |